Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs LUPIN - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

LUPIN 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA LUPIN ABBOTT INDIA/
LUPIN
 
P/E (TTM) x 48.6 -303.0 - View Chart
P/BV x 15.9 3.9 402.0% View Chart
Dividend Yield % 0.4 0.5 79.0%  

Financials

 ABBOTT INDIA   LUPIN
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
LUPIN
Mar-20
ABBOTT INDIA/
LUPIN
5-Yr Chart
Click to enlarge
High Rs8,834882 1,001.4%   
Low Rs5,458505 1,080.7%   
Sales per share (Unadj.) Rs1,731.1339.4 510.1%  
Earnings per share (Unadj.) Rs211.9-5.9 -3,563.6%  
Cash flow per share (Unadj.) Rs219.915.5 1,421.3%  
Dividends per share (Unadj.) Rs65.006.00 1,083.3%  
Dividend yield (eoy) %0.90.9 105.2%  
Book value per share (Unadj.) Rs945.2276.7 341.5%  
Shares outstanding (eoy) m21.25453.00 4.7%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x4.12.0 202.0%   
Avg P/E ratio x33.7-116.6 -28.9%  
P/CF ratio (eoy) x32.544.8 72.5%  
Price / Book Value ratio x7.62.5 301.6%  
Dividend payout %30.7-100.9 -30.4%   
Avg Mkt Cap Rs m151,848314,201 48.3%   
No. of employees `0003.518.3 19.0%   
Total wages/salary Rs m4,35629,868 14.6%   
Avg. sales/employee Rs Th10,555.58,400.6 125.7%   
Avg. wages/employee Rs Th1,249.91,632.0 76.6%   
Avg. net profit/employee Rs Th1,292.2-147.2 -877.9%   
INCOME DATA
Net Sales Rs m36,786153,748 23.9%  
Other income Rs m1,1334,838 23.4%   
Total revenues Rs m37,919158,585 23.9%   
Gross profit Rs m6,04724,849 24.3%  
Depreciation Rs m1699,702 1.7%   
Interest Rs m233,630 0.6%   
Profit before tax Rs m6,98916,355 42.7%   
Minority Interest Rs m04 0.0%   
Prior Period Items Rs m039 0.0%   
Extraordinary Inc (Exp) Rs m0-7,521 0.0%   
Tax Rs m2,48511,571 21.5%   
Profit after tax Rs m4,503-2,694 -167.2%  
Gross profit margin %16.416.2 101.7%  
Effective tax rate %35.670.8 50.3%   
Net profit margin %12.2-1.8 -698.7%  
BALANCE SHEET DATA
Current assets Rs m27,610154,132 17.9%   
Current liabilities Rs m8,56992,252 9.3%   
Net working cap to sales %51.840.2 128.6%  
Current ratio x3.21.7 192.9%  
Inventory Days Days6082 73.4%  
Debtors Days Days27129 21.2%  
Net fixed assets Rs m1,05789,082 1.2%   
Share capital Rs m213906 23.5%   
"Free" reserves Rs m19,873124,461 16.0%   
Net worth Rs m20,086125,367 16.0%   
Long term debt Rs m017,933 0.0%   
Total assets Rs m29,409249,839 11.8%  
Interest coverage x311.65.5 5,659.6%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.30.6 203.3%   
Return on assets %15.40.4 4,108.1%  
Return on equity %22.4-2.1 -1,043.4%  
Return on capital %34.98.7 399.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m36951,450 0.7%   
Fx outflow Rs m4,91819,470 25.3%   
Net fx Rs m-4,54931,980 -14.2%   
CASH FLOW
From Operations Rs m4,99114,688 34.0%  
From Investments Rs m-2,57011,070 -23.2%  
From Financial Activity Rs m-1,428-8,906 16.0%  
Net Cashflow Rs m99316,853 5.9%  

Share Holding

Indian Promoters % 0.0 46.6 -  
Foreign collaborators % 75.0 0.2 37,500.0%  
Indian inst/Mut Fund % 7.9 11.3 69.9%  
FIIs % 0.1 31.9 0.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 10.1 169.3%  
Shareholders   18,270 98,259 18.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   AUROBINDO PHARMA  ORCHID PHARMA  PFIZER  J.B.CHEMICALS  SHASUN PHARMA  

Compare ABBOTT INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

5 Reasons Why Sensex and Nifty Fell Over 1% Today(Closing)

Indian share markets witnessed heavy selling pressure today, pausing the record rally, with all sectors barring telecom, reeling under pressure.

Related Views on News

LUPIN 2019-20 Annual Report Analysis (Annual Result Update)

Dec 7, 2020 | Updated on Dec 7, 2020

Here's an analysis of the annual report of LUPIN for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

LUPIN Announces Quarterly Results (2QFY21); Net Profit Up 271.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, LUPIN has posted a net profit of Rs 2 bn (up 271.3% YoY). Sales on the other hand came in at Rs 38 bn (down 12.0% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN Announces Quarterly Results (1QFY21); Net Profit Down 64.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, LUPIN has posted a net profit of Rs 1 bn (down 64.2% YoY). Sales on the other hand came in at Rs 35 bn (down 20.2% YoY). Read on for a complete analysis of LUPIN's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY21); Net Profit Up 54.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY20); Net Profit Down 2.0% (Quarterly Result Update)

Jun 9, 2020 | Updated on Jun 9, 2020

For the quarter ended March 2020, ABBOTT INDIA has posted a net profit of Rs 1 bn (down 2.0% YoY). Sales on the other hand came in at Rs 10 bn (up 6.1% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

My Top Stock Recommendation for 2021 and Beyond(Profit Hunter)

Jan 5, 2021

My new guide will show you the huge potential in future proof businesses.

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Five Wishes and a Will(The Honest Truth)

Jan 4, 2021

Ajit Dayal on the investing strategy for 2021 and beyond.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jan 15, 2021 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - SANOFI INDIA COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS